SPONSOR
Vanderbilt-Ingram Cancer Center
Total Trials
5
Recruiting
5
Phases
EARLY_Phase 1
Conditions studied: MelanomaBreast CancerClonal HematopoiesisLocally Advanced CancerMetastatic CancerHER2HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell CarcinomaHER 2 Low-expressing Breast CancerHead and Neck Squamous Cell CarcinomaBrain Metastases
Vanderbilt-Ingram Cancer Center is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Melanoma, Breast Cancer, Clonal Hematopoiesis, Locally Advanced Cancer.
The trial portfolio spans EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Vanderbilt-Ingram Cancer Center
How many clinical trials has Vanderbilt-Ingram Cancer Center sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Vanderbilt-Ingram Cancer Center, of which 5 are actively recruiting participants. These trials cover conditions including Melanoma, Breast Cancer, Clonal Hematopoiesis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Vanderbilt-Ingram Cancer Center research focus on?
Vanderbilt-Ingram Cancer Center clinical trials span Melanoma, Breast Cancer, Clonal Hematopoiesis, Locally Advanced Cancer, Metastatic Cancer, and additional conditions. The research pipeline includes EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Vanderbilt-Ingram Cancer Center clinical trial?
To participate in a Vanderbilt-Ingram Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Vanderbilt-Ingram Cancer Center trials with current recruitment status updated daily.
Clinical Trials by Vanderbilt-Ingram Cancer Center
NCT01205815
Recruiting
Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
Melanoma
NCT00899301
Recruiting
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Breast Cancer
NCT06701214
Recruiting
The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository
Clonal Hematopoiesis
NCT06828588 EARLY_Phase 1
Recruiting
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Locally Advanced Cancer
NCT05996432 EARLY_Phase 1
Recruiting
Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy
Head and Neck Squamous Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology